FDA Approves Use of Afluria®, Influenza Vaccine with PharmaJet’s Needle-Free Injector

KING OF PRUSSIA, Penn. / GOLDEN, Colo. – August 19, 2014 – PharmaJet® Inc., the developer of a needle-free injection technology to administer medications and vaccines to patients, and bioCSL Inc., the maker of AFLURIA® (Influenza Vaccine) today announced the U.S. Food and Drug Administration (FDA) has approved the PharmaJet Stratis® 0.5mL Needle-Free Jet Injector...

Unreported Needlestick Injuries

In the United States, 600,000-800,000 needlestick injuries are documented each year, yet studies have indicated that oftentimes these incidents go unreported.1 This begs the question: How truly prevalent are these events in the healthcare industry and why are they going undocumented?